Follow
Lyndsey Collins-Praino
Lyndsey Collins-Praino
Verified email at adelaide.edu.au
Title
Cited by
Cited by
Year
Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors
AM Farrar, KN Segovia, PA Randall, EJ Nunes, LE Collins, CM Stopper, ...
Neuroscience 166 (4), 1056-1067, 2010
1312010
The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit …
AM Mott, EJ Nunes, LE Collins, RG Port, KS Sink, J Hockemeyer, ...
Psychopharmacology 204, 103-112, 2009
1232009
Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism
JD Salamone, AM Farrar, L Font, V Patel, DE Schlar, EJ Nunes, ...
Behavioural brain research 201 (1), 216-222, 2009
1122009
Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis
D Saredakis, LE Collins-Praino, DS Gutteridge, BCM Stephan, ...
Parkinsonism & Related Disorders 65, 20-31, 2019
1062019
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
KS Sink, KN Segovia, J Sink, PA Randall, LE Collins, M Correa, ...
European Neuropsychopharmacology 20 (2), 112-122, 2010
942010
Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?
LE Collins-Praino, F Corrigan
Brain, behavior, and immunity 60, 369-382, 2017
862017
Soluble amyloid beta levels are elevated in the white matter of Alzheimer’s patients, independent of cortical plaque severity
LE Collins-Praino, YI Francis, EY Griffith, AF Wiegman, J Urbach, ...
Acta neuropathologica communications 2, 1-10, 2014
852014
APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?
AM Brickman, N Schupf, JJ Manly, Y Stern, JA Luchsinger, ...
Alzheimer's & Dementia 10 (6), 619-629, 2014
812014
Neuroinflammation as a key driver of secondary neurodegeneration following stroke?
SM Stuckey, LK Ong, LE Collins-Praino, RJ Turner
International Journal of Molecular Sciences 22 (23), 13101, 2021
642021
Evolution and significance of the triple risk model in sudden infant death syndrome
J Spinelli, L Collins‐Praino, C Van Den Heuvel, RW Byard
Journal of paediatrics and child health 53 (2), 112-115, 2017
622017
The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats
KS Sink, KN Segovia, LE Collins, EJ Markus, VK Vemuri, A Makriyannis, ...
Pharmacology Biochemistry and Behavior 95 (4), 479-484, 2010
612010
Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: effects on locomotor activity
LE Collins, DJ Galtieri, P Collins, SK Jones, RG Port, NE Paul, ...
Behavioural brain research 211 (2), 148-155, 2010
602010
The effect of an acute systemic inflammatory insult on the chronic effects of a single mild traumatic brain injury
LE Collins-Praino, A Arulsamy, V Katharesan, F Corrigan
Behavioural brain research 336, 22-31, 2018
482018
Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor
LE Collins-Praino, NE Paul, KL Rychalsky, JR Hinman, JJ Chrobak, ...
Frontiers in systems neuroscience 5, 49, 2011
442011
Role of dopamine–adenosine interactions in the brain circuitry regulating effort-related decision making: insights into pathological aspects of motivation
JD Salamone, M Correa, AM Farrar, EJ Nunes, LE Collins
Future Neurology 5 (3), 377-392, 2010
442010
Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation
F Corrigan, A Arulsamy, LE Collins-Praino, JL Holmes, R Vink
Brain, behavior, and immunity 64, 124-139, 2017
432017
The novel adenosine A2A antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions
JL Santerre, EJ Nunes, R Kovner, CE Leser, PA Randall, ...
Pharmacology Biochemistry and Behavior 102 (4), 477-487, 2012
432012
The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade
LE Collins, TN Sager, AG Sams, A Pennarola, RG Port, M Shahriari, ...
Pharmacology Biochemistry and Behavior 100 (3), 498-505, 2012
392012
The need to incorporate aged animals into the preclinical modeling of neurological conditions
M Sun, SJ McDonald, RD Brady, L Collins-Praino, GR Yamakawa, ...
Neuroscience & Biobehavioral Reviews 109, 114-128, 2020
382020
Oral tremor induced by galantamine in rats: A model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease
LE Collins, NE Paul, SF Abbas, CE Leser, SJ Podurgiel, DJ Galtieri, ...
Pharmacology Biochemistry and Behavior 99 (3), 414-422, 2011
342011
The system can't perform the operation now. Try again later.
Articles 1–20